{"id":2809,"date":"2019-10-08T13:05:38","date_gmt":"2019-10-08T11:05:38","guid":{"rendered":"https:\/\/idibell.cat\/?page_id=2809"},"modified":"2024-04-18T12:00:16","modified_gmt":"2024-04-18T10:00:16","slug":"diagnostico-por-la-imagen-y-medicina-nuclear","status":"publish","type":"page","link":"https:\/\/idibell.cat\/es\/investigacion\/area-de-medicina-traslacional\/programa-de-sistema-digestivo-diagnostic-farmacogenetica-enfermeria-y-prevencion-clinica\/diagnostico-por-la-imagen-y-medicina-nuclear\/","title":{"rendered":"Diagn\u00f3stico por la Imagen y Medicina Nuclear"},"content":{"rendered":"\n
El grupo focaliza a su investigaci\u00f3n en la mejora de las t\u00e9cnicas de diagn\u00f3stico por la imagen y la medicina nuclear aplicadas a varias enfermedades, como las infecciosas o las inflamatorias, y a varios tipos de tumores.<\/p>\n
Gin\u00e9,E;de la Cruz,F;Jim\u00e9nez Ubieto,A;L\u00f3pez Jimenez,J;Mart\u00edn Garc\u00eda Sancho,A;Terol,MJ;Gonz\u00e1lez Barca,E et al, Ibrutinib in Combination With Rituximab for Indolent Clinical Forms of Mantle Cell Lymphoma (IMCL-2015): A Multicenter, Open-Label, Single-Arm, Phase II Trial<\/strong>., J. Clin. Oncol., 2022;40(11):1196-1205, doi:10.1200\/JCO.21.02321<\/p>\n Mils,K;Mir\u00f3,M;Farran,L;Videla,S;Alba,E;Estremiana,F;Bettonica,C et al, A pilot randomized controlled trial on the utility of gastric conditioning in the prevention of esophagogastric anastomotic leak after Ivor Lewis esophagectomy<\/strong>., Int. J. Surg., 2022;106106921-106921, doi:10.1016\/j.ijsu.2022.106921<\/p>\n Requena,M;Ribo,M;Zamarro,J;Vega,P;Blasco,J;Gonz\u00e1lez,EM;Del Mar Freijo,M et al, Clinical Results of the Advanced Neurovascular Access Catheter System Combined With a Stent Retriever in Acute Ischemic Stroke (SOLONDA)<\/strong>., Stroke, 2022;53(7):2211-2219, doi:10.1161\/STROKEAHA.121.037577<\/p>\n Font,M\u00c0;Garc\u00eda S\u00e1nchez,SM;Mengual,JJ;Mena,L;Avellaneda,C;Serena,J;Valls Carb\u00f3,A et al, Determinants and Trends of the Use of Intravenous Thrombolysis for Minor Stroke: A Population-Based Study, 2016 to 2020<\/strong>., Stroke, 2022;53(11):3289-3294, doi:10.1161\/STROKEAHA.122.038996<\/p>\n Arribas,L;Sabat\u00e9 Llobera,A;Domingo,MC; Taberna,M; Sospedra,M; Martin,L; Gonz\u00e1lez Tamp\u00e1n,AR et al, Assessing dynamic change in muscle during treatment of patients with cancer: Precision testing standards<\/strong>., Clin. Nutr., 2022;41(5):1059-1065, doi:10.1016\/j.clnu.2022.03.016<\/p>\n\t\t\t\t\tProyectos seleccionados<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\t 18ACL106. A RANDOMIZED, OPEN-LABEL, MULTICENTER PHASE 3 STUDY TO COMPARE THE EFFICACY AND SAFETY OF BGB-A317 VERSUS SORAFENIB AS FIRST-LINE TREATMENT IN PATIENTS WITH UNRESECTABLE HEPATOCELLULAR CARCINOMA<\/strong>. Budget: 30870. 2018- . PI: De Lama SALVADOR, M\u00aa Eugenia.<\/p>\n 19ACL037. A RANDOMIZED, CONTROLLED, OPEN-LABEL, GLOBAL PHASE 3 STUDY COMPARING THE EFFICACY OF THE ANTI-PD-1 ANTIBODY BGB-A317 VERSUS CHEMOTHERAPY AS SECOND LINE TREATMENT IN PATIENTS WITH ADVANCED UNRESECTABLE\/METASTATIC ESOPHAGEAL SQUAMOUS CELL CARCINOMA<\/strong>. Budget: 1633,94. 2019- . PI: Calvo Malvar, Nahum.<\/p>\n 2022-113-1. TERAPIA CON RADIOP\u00c9PTIDOS EN PR\u00c1CTICA CL\u00cdNICA<\/strong>. Sociedad Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (SEMNIM). 2022- . PI: Vercher Conejero, Jos\u00e9 Luis.<\/p>\n 14ACL069. ESTUDIO DE FASE II ABIERTO, ALEATORIZADO, DE TRES GRUPOS, DE DICLORURO DE RADIO-223 DE 50 kBq\/kg (55 kBq\/kg TRAS IMPLEMENTAR LA ACTUALIZACI\u00d3N DEL NIST) EN COMPARACI\u00d3N CON 80 kBq\/kg (88 kBq\/kg TRAS IMPLEMENTAR LA ACTUALIZACI\u00d3N DEL NIST) y 50 kBq\/kg (55 kBq\/kg TRAS IMPLEMENTAR LA ACTUALIZACI\u00d3N DEL NIST) EN UN PROGRAMA DE DOSIS AMPLIADO EN PACIENTES CON C\u00c1NCER DE PR\u00d3STATA RESISTENTE A LA CASTRACI\u00d3N CON MET\u00c1STASIS \u00d3SEA<\/strong>. 2014- . PI: Mora Salvado, Jaume.<\/p>\n 12ACL078. ESTUDIO EN FASE III ABIERTO, ALEATORIZADO, MULTIC\u00c9NTRICO, ESTRATIFICADO, DE COMPARADOR ACTIVO Y DE GRUPOS PARALELOS PARA COMPARAR EL TRATAMIENTO CON 177Lu-DOTA0-Tyr3-ACETATO DE OCTREOTIDA FRENTE A OCTREOTIDA DE ACCI\u00d3N PROLONGADA EN PACIENTES CON TUMORES CARCINOIDES DEL INTESTINO MEDIO IRRESECABLES, PROGRESIVOS, POSITIVOS PARA RECEPTORES DE SOMATOSTATINA<\/strong>. 2012-2023. PI: Mora Salvado, Jaume.<\/p>\n\t\t\t\t\n Diagn\u00f3stico por la Imagen y Medicina Nuclear Resumen El grupo focaliza a su investigaci\u00f3n en la mejora de las t\u00e9cnicas de diagn\u00f3stico por la imagen y la medicina nuclear aplicadas a varias enfermedades, como las infecciosas o las inflamatorias, y a varios tipos de tumores. 491 Publicaciones L\u00edneas estrat\u00e9gicas Expand Diagn\u00f3stico de la infecci\u00f3n osteoarticular. […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":579,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"disabled","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"footnotes":""},"publishpress_future_action":{"enabled":false,"date":"2024-05-07 06:49:54","action":"change-status","newStatus":"draft","terms":[],"taxonomy":""},"_links":{"self":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/pages\/2809"}],"collection":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/comments?post=2809"}],"version-history":[{"count":7,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/pages\/2809\/revisions"}],"predecessor-version":[{"id":24183,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/pages\/2809\/revisions\/24183"}],"up":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/pages\/579"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/media?parent=2809"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}\n\t\tCalvo Malvar, Nahum\n\t<\/h4>\n
\n\t\t\n\t\tncalvom@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\n
\n\t\tCort\u00e9s Romera, Montserrat\n\t<\/h4>\n
\n\t\tInvestigadores principales\n\t<\/h2>\n\t\t\t\t\n
\n\t\tCalvo Malvar, Nahum\n\t<\/h4>\n
\n\t\t\n\t\tncalvom@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\n
\n\t\tCort\u00e9s Romera, Montserrat\n\t<\/h4>\n\t\t\t\t\n
\n\t\tSabat\u00e9 Llobera, Aida\n\t<\/h4>\n
\n\t\t\n\t\tasabate@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n
\n\t\tEquipo\n\t<\/h2>\n\t\t\t\t\t\t\t\t\t\t\t\tJefes\/as de grupo\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tInvestigadores\/as principales\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tInvestigadores\/as cl\u00ednicos\/cas\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tInvestigadores\/as postdoctorales\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tSoporte cient\u00edfico\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tSoporte de gesti\u00f3n\t\t\t\t<\/a>\n\t\t\t\t\t\tJefes\/as de grupo\n\t\t\t\t\t\t\t\t\t\t\t
\n
\n
\n
\n
\n
\n
\n\t\tNoticias relacionadas\n\t<\/h2>\n\t\t\n\t\t\t\t<\/a>\n\t\t\tDescritos nuevos factores predictores de mortalidad en la embolia pulmonar grave<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t05\/11\/2021\t\t\t\t\t\t\t\n\t\t\n\n","protected":false},"excerpt":{"rendered":"